AAAAAA

   
Results: 1-10 |
Results: 10
Clinical and subclinical body dysmorphic disorder
Authors: Altamura, C Paluello, MM Mundo, E Medda, S Mannu, P
Citation: C. Altamura et al., Clinical and subclinical body dysmorphic disorder, EUR ARCH PS, 251(3), 2001, pp. 105-108
Duration of untreated psychosis as a predictor of outcome in first-episodeschizophrenia: a retrospective study
Authors: Altamura, AC Bassetti, R Sassella, F Salvadori, D Mundo, E
Citation: Ac. Altamura et al., Duration of untreated psychosis as a predictor of outcome in first-episodeschizophrenia: a retrospective study, SCHIZOPHR R, 52(1-2), 2001, pp. 29-36
The 5HT1D beta receptor gene in Bipolar Disorder: A family-based association study
Authors: Mundo, E Zai, G Lee, L Parikh, SV Kennedy, JL
Citation: E. Mundo et al., The 5HT1D beta receptor gene in Bipolar Disorder: A family-based association study, NEUROPSYCH, 25(4), 2001, pp. 608-613
Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine
Authors: Mundo, E Rouillon, F Figuera, ML Stigler, M
Citation: E. Mundo et al., Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine, HUM PSYCHOP, 16(6), 2001, pp. 461-468
The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder - Preliminary findings
Authors: Mundo, E Walker, M Cate, T Macciardi, F Kennedy, JL
Citation: E. Mundo et al., The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder - Preliminary findings, ARCH G PSYC, 58(6), 2001, pp. 539-544
5-HT1D function and repetitive behaviors - Dr. Mundo and colleagues reply
Authors: Mundo, E Richter, MA Sam, F Macciardi, F Kennedy, JL
Citation: E. Mundo et al., 5-HT1D function and repetitive behaviors - Dr. Mundo and colleagues reply, AM J PSYCHI, 158(6), 2001, pp. 973-973
Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder
Authors: Mundo, E Maina, G Uslenghi, C
Citation: E. Mundo et al., Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder, INT CLIN PS, 15(2), 2000, pp. 69-76
Lack of linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and bipolar disorder
Authors: Mundo, E Walker, M Tims, H Macciardi, F Kennedy, JL
Citation: E. Mundo et al., Lack of linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and bipolar disorder, AM J MED G, 96(3), 2000, pp. 379-383
Is the 5-HT1D beta receptor gene implicated in the pathogenesis of obsessive-compulsive disorder?
Authors: Mundo, E Richter, MA Sam, F Macciardi, F Kennedy, JL
Citation: E. Mundo et al., Is the 5-HT1D beta receptor gene implicated in the pathogenesis of obsessive-compulsive disorder?, AM J PSYCHI, 157(7), 2000, pp. 1160-1161
Effect of acute intravenous clomipramine and antiobsessional response to proserotonergic drugs: Is gender a predictive variable?
Authors: Mundo, E Bareggi, SR Pirola, R Bellodi, L
Citation: E. Mundo et al., Effect of acute intravenous clomipramine and antiobsessional response to proserotonergic drugs: Is gender a predictive variable?, BIOL PSYCHI, 45(3), 1999, pp. 290-294
Risultati: 1-10 |